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Methicillin Resistant Staphylococcus aureus in Patients Undergoing
Major Amputation
S. A. J. Grimble, T. R. Magee and R. B. Galland∗
Department of Surgery, Royal Berkshire Hospital, Reading
Objectives: to examine the impact of MRSA infection on patients undergoing major amputation.
Setting: District General Hospital.
Methods: patients having had major amputation and positive MRSA cultures January 1995–December 1999 were
included. Outcome was compared with a randomly chosen group of patients having major amputation but no positive
MRSA culture from the same time period.
Results: overall 21% of patients undergoing amputation were MRSA positive. Some 28 patients (30 amputations) with
MRSA positive cultures were compared with 44 patients (54 amputations) who did not have positive cultures for MRSA.
MRSA was isolated from the wound in 17 of 30 amputations. More patients in the control group had a below knee
amputation (38 of 54 compared with 12 of 30, p<0.02). Mortality in MRSA positive patients was higher than controls,
(12 of 28, 43%, versus 4 of 44, 9%, p<0.01). Primary healing was achieved in only 4 of 17 (24%) amputations where
MRSA was isolated from the wound. This compared with 31 of 54 (57%) controls (p<0.05). Delayed healing due to
chronic infection was also more likely in MRSA positive patients (p<0.01).
Conclusion: in view of the high morbidity and mortality in patients with MRSA positive isolates specific antibiotic
prophylaxis against MRSA should be considered in patients undergoing major amputation.
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Introduction In a recent multicentre survey of patients under-
going vascular operations almost half of wound and
The number of patients being diagnosed as having graft infections diagnosed were due to MRSA.6 MRSA-
infected wounds were significantly more likely to tomethicillin resistant Staphylococcus aureus (MRSA) in-
fection is increasing.1 The incidence of MRSA in hos- progress to major amputation or ongoing infection
than wounds infected with other organisms.pital patients had reached 13.5% of S. aureus infections
by 1995.2 The aim of this study was to examine the impact of
MRSA infection in those patients who had undergoneIn a previous study we found that MRSA-infected
general surgical patients were sicker and had sustained a major amputation.
a greater surgical insult than non-MRSA-infected
patients.3
Patients undergoing arterial operations are at con- Methods
siderable risk of acquiring infection. Patients not re-
ceiving prophylactic antibiotics have been shown to Patients having had major amputation and positive
have a groin wound infection rate of approximately MRSA swabs between January 1995 and December
25%.4 Infection of synthetic vascular grafts though 1999 were included. They were identified by cross
uncommon has dire consequences, with high rates of checking data from the microbiology laboratory com-
limb loss and death.5 Though prophylactic antibiotics puter against theatre ledgers. During this time it was
have proved effective in the past the emergence of not hospital policy routinely to screen all patients for
MRSA is challenging vascular surgeons and micro- MRSA. However, once a positive swab from a primary
biologists alike. site (e.g. wound, sputum, blood or urine) was obtained,
these patients had swabs taken from nose, axilla, peri-
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details of patients with MRSA-positive swabs and
controls. In patients with MRSA the indication for
amputation was gangrene in 12, ulceration in nine and
rest pain in the remainder. For the control patients the
indication was gangrene in nine, ulceration in 15, the
remainder having rest pain. Of patients who were
MRSA positive three had previous contralateral am-
putations, which had not been complicated by MRSA.
Control patients were more likely to have undergone
a below knee amputation than patients with positive
Fig. 1. Total number of major amputations 1995–1999 showing MRSA cultures. (Chi-squared 6.2, df 1, p<0.02).
numbers being MRSA positive. In 17 cases MRSA was isolated from the amputation
wound. Other sites of infection or contamination werepatients who had undergone major amputation with-
skin (13), blood (2), graft (2), urine (2) and an infectedout identifiable MRSA infection or colonisation. These
feeding line (1). Multiple sites of infection were iden-‘‘control’’ patients were identified from the operating
tified in 8 cases. MRSA was first identified beforeledgers. We randomly chose patients who had op-
amputation in 16 and following amputation in 14.erations as close as possible in time to those of the
All patients had prophylactic antibiotics to coverstudy group. The patients and amputations were not
the time of the amputation (either metronidazole ormatched in any other way. Not all patients having
penicillin). In addition vancomycin was given in onemajor amputation during the time of the study were
case and teicoplanin in three. Postoperatively teico-included in this control group.
planin or vancomycin was given to all patients withStastistical analysis was carried out using Chi-
MRSA isolated from wound, blood or graft site or ifsquared test with continuity correction for small num-
they were systemically unwell with sepsis.bers.
Co-existing infections were present in 8 patients, the
most common being a coliform urinary tract infection
(5). Others included pseudomonas chest infection (2)
Results and clostridium difficile diarrhoea (1).
Outcome is shown in Table 2. Mortality in patients
During the five years of the study 153 major am- who were MRSA positive was 12 of 28 (43%), compared
putations were carried out. A total of 28 patients with four of 44 (9%) in the control patients (Chi-
(30 amputations) were found to have MRSA positive squared 9.42, df 1, p<0.01). Patients with MRSA in
swabs. There was a steady increase in the number of their wounds fared particularly badly. Nine of seven-
patients having amputations who tested positive for teen (53%) patients with MRSA in their wound died
MRSA during the first four years of the study, with a compared with four of 44 (9%) controls, (Chi-squared
slight decrease in 1999 (Fig 1). Overall 20% of am- 11.6, df 1, p<0.001).
putations were complicated by the patient having There was no difference in mortality in patients
MRSA isolated. having MRSA in their wounds compared with those
in whom MRSA was found elsewhere. Primary healingTable 1 illustrates the demographic and amputation
Table 1. Demographic and amputation details.
MRSA isolated Controls
n (%) n (%)
Patients 28 44
Men 20 (71) 34 (77)
Age, median (range) 71 (49–90) 73 (41–85)
Diabetes mellitus 18 (64) 21 (47)
Hypertension 10 (36) 18 (41)
Ischaemic heart disease 10 (36) 16 (36)
Hypercholesterolaemia 3 (11) 2 (5)
Continued to smoke 10 (36) 13 (30)
Amputations 30 54
Below knee 12 (40) 38 (70)
Above knee 14 (47) 15 (28)
Through knee 4 (13) 1 (2)
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Table 2. Outcome: MRSA patients versus controls. Figures in brackets represent percentages.
MRSA Controls
In wound Not in wound Total
n patients 17 11 28 44
n amputations 17 13 30 54
Primary healing 4 (24) 7 (54) 11 (37) 31 (57)
Secondary healing 13 (76) 6 (46) 19 (63) 23 (43)
Delayed healing 4 (24) 2 (15) 6 (20) 0 (0)
Refashioning 5 (29) 0 (0) 5 (17) 10 (19)
Death 9 (53) 3 (27) 12 (43) 4 (9)
occurred in four of 17 (24%) amputations from which with approximately 10% for below knee amputations.9
It is possible that part of the high mortality we haveMRSA was grown in the wound, compared with 31
of 54 (57%) controls (Chi-squared 4.6, df 1, p<0.05). shown in MRSA positive patients may be due to the
high proportion of above knee amputations in thisThere was no significant difference in the rate of
refashioning in the two groups. Healing was delayed group. However a mortality in patients undergoing
major amputation with clinical evidence of MRSAfor more than six months, due to chronic infection,
in six amputations (21%). This only occurred in the infection has been described by others.10 Of 14 patients
described by Murphy et al. five died (36%). Overpresence of MRSA (Chi-squared 8.8, df 1, p<0.01).
Healing did occur in these patients, but the median half of those amputations were below knee. Primary
healing is more likely in patients undergoing abovetime to healing was 12 months (range 6–24 months).
compared with below knee amputations. Despite the
case-mix in this study which has resulted in a greater
proportion of below knee amputations in the control
Discussion group, healing in these patients was significantly better
than those patients who had MRSA isolated from their
Over the period 1984–1991 the proportion of S. aureus amputation wounds. Furthermore, delayed healing
resistant to methicillin isolated in American hospitals was more likely in those patients in the MRSA group.
rose from 5%to 29%.7 This trend is mirrored world- The choice of above knee amputation for this group
wide. MRSA infection in patients undergoing arterial of patients probably represents their general frailty.
perations is similarly increasing. Nasim et al showed We have previously shown that this group of patients
a five-fold increase between 1993–1998.8 Our results, are particularly likely to sustain MRSA infection.4
with regard to MRSA being diagnosed in patients Antibiotic prophylaxis for patients undergoing
undergoing major amputation show a similar pattern. major amputation has been mainly directed towards
There was a small but steady increase 1995–1997 preventing gas gangrene using metronidazole or peni-
with a four-fold increase in the subsequent twelve cillin.11 This policy should clearly be reassessed. Use
months. This was not associated with any change in of an antibiotic such as vancomycin or teicoplanin can
antibiotic prophylactic policy nor in increasing efforts probably be justified in view of the data provided in
to diagnose MRSA on cultures. this study.
It is difficult to be certain which of the patients in
this study had MRSA infection or simple colonisation.
However, once MRSA had been isolated the likelihood
of death following major amputation is significantly
increased. The aggressive nature of MRSA in patients References
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